Introduction
============

The global dissemination of carbapenem-resistant Enterobacteriaceae (CRE) has become a major threat to public health. With the increasing global prevalence of New Delhi metallo-β-lactamase (NDM)-producing bacteria, which are highly disseminated in China ([@B9]), available antibiotics are becoming less effective in the treatment of drug-resistant bacterial infections. Since NDM was first reported in India ([@B20]), the sequences of 18 NDM variants (NDM-19 unpublished) have been reported. NDMs may be evolving diverse hydrolytic activity toward β-lactams, resulting from amino acid substitutions or insertions ([@B9]), subsequently, it may affect treatment strategy. In addition, these bacteria producing NDM variants are disseminated not only among humans, but also in food animals ([@B19]). Even though food-producing animals serve as the major reservoir of NDM-producing bacteria ([@B11]), apart from our previous description of NDM-17 ([@B10]), studies on NDM variants of animal-derived bacterial isolates are limited. So, it is important and necessary to monitor NDM evolution in food animals. Here, a novel NDM variant, NDM-20, was identified in an *Escherichia coli* strain isolated from swine, and was subjected to in-depth molecular characterization.

Materials and Methods {#s1}
=====================

Isolation and Identification of the Bacterial Strain and Phenotypic Screening for MBL Production
------------------------------------------------------------------------------------------------

To better understand the prevalence of CRE, a routine surveillance of antimicrobial resistance in bacteria of food-producing animal origin was carried out in Shandong province, China, in 2016. The swine anal swab samples were collected and enriched in 5 mL of brain heart infusion broth before being plated onto CHROMagar KPC medium (CHROMagar, Paris, France) for CRE selection. Then, the resistant strains were identified on MHA medium containing 1 mg/L of meropenem. Strain CCD1 was isolated from a swine fecal swab sample from a commercial farm. Identification of the bacterial species was performed by MALDI-TOF MS (Bruker Daltonik, Bremen, Germany) and 16S rRNA sequencing, as described previously ([@B18]). To detect carbapenemase production, the modified Hodge test was carried out using imipenem and meropenem disks, and for MBL production test, the combined-disk was performed by imipenem with and without EDTA.

Antimicrobial Susceptibility Testing and Detection of Antibiotic Resistance Genes
---------------------------------------------------------------------------------

Antimicrobial susceptibility testing of isolates was carried out using the broth microdilution method, and the results in triplicate with best repeatability were interpreted according to the CLSI and EUCAST (version 7.1) guidelines ([@B2]; [@B5]). The tested isolates and antimicrobial agents are listed in **Table [1](#T1){ref-type="table"}**, and *E. coli* ATCC 25922 was used as a quality control strain. Carbapenemase-encoding genes *bla*~KPC~, *bla*~V\ IM~, *bla*~IMP~, *bla*~NDM~, *bla*~OXA-23-like~, *bla*~OXA-58-like~, *bla*~OXA-48-like~, *bla*~IND~, *bla*~KHM~, *bla*~DIM~, *bla*~GIM~, *bla*~SIM~, and *bla*~SPM~, and β-lactamase-encoding genes *bla*~TEM~, *bla*~SHV~, and *bla*~CTX-M~ were screened as previously described ([@B4]; [@B14]; [@B22]), and *bla*~NDM~ was screened by primer preA and preB in **Supplementary Table [S1](#SM5){ref-type="supplementary-material"}**. PCR amplicons were sequenced and then analyzed against the GenBank database.

###### 

The resistance gene(s) in CCD1 and β-lactam MICs for the New Delhi metallo-β-lactamase (NDM)-carrying *Escherichia coli* clinical isolate, transconjugants, and transformants.

  Antibiotics*^a^*   MIC (mg/L) for strains                                        
  ------------------ ------------------------ ------- ------ ------- ------ ------ ------
  Ampicillin         \>512                    \>512   2      2       512    512    512
  Amoxicillin        \>512                    512     16     1       512    512    512
  Amoxicillin+CLA    128                      128     16     2       128    128    128
  Aztreonam          256                      0.12    0.06   0.06    0.03   0.03   0.06
  Ceftazidime        \>512                    \>512   1      0.5     512    256    128
  Cefoxitin          512                      512     8      4       256    128    256
  Cefazolin          \>512                    \>512   4      2       256    256    256
  Cefotaxime         512                      512     0.12   0.03    32     32     32
  Cefepime           512                      256     0.12   0.015   4      2      2
  Ertapenem          128                      64      0.06   0.015   1      2      0.25
  Imipenem           128                      64      0.5    0.125   4      4      4
  Meropenem          128                      64      0.12   0.03    2      4      2
  Penicillin G       \>512                    \>512   32     16      512    512    512
  Piperacillin       \>512                    \>512   16     0.5     16     16     16
  Piperacillin+TZB   \>512                    \>512   16     0.5     16     16     16
  Colistin           0.25                     0.12    0.25   0.12    0.12   0.12   0.12
  Gentamicin         1                        2       2      1       1      1      1
  Tigecycline        0.06                     0.06    0.06   0.06    0.06   0.03   0.03

a

CLA, clavulanic acid (fixed concentration of 2 mg/L); TZB, tazobactam (fixed concentration of 4 mg/L)

.

Conjugation Assay and Location Analysis of *bla*~NDM~
-----------------------------------------------------

To determine the transferability of *bla*~NDM~, transconjugation was attempted using *E. coli* J53 as the recipient ([@B10]). Transconjugants were selected on MacConkey agar supplemented with 100 mg/L sodium azide and 1 mg/L meropenem, and confirmed by PCR and sequencing. The transfer frequency was determined from the ratio of transconjugants: donors. Location analysis of *bla*~NDM~ was performed by S1-PFGE and Southern blotting, as described previously ([@B1]).

Resistome and Plasmid Analysis
------------------------------

To further confirm the resistance gene profile of strain CCD1 and to determine the genetic background of *bla*~NDM~, the genomic DNA of strain CCD1, including plasmid pNDM-20, was extracted and subjected to WGS, as reported previously ([@B10]; [@B19]). A 250-bp paired-end library was constructed using a NEXT Ultra DNA Library Prep kit (New England Biolabs, E7645L) and an Illumina Hiseq 2500 system (Bionova Biotech, Co., Beijing, China). The raw sequencing data were then *de novo* assembled and examined for the presence of resistance genes using CLC Genomics Workbench 9.0 (CLC Bio, Aarhus, Denmark) against resistance gene database based on CARD. SRST2 was used for MLST analysis of strain CCD1 using the sequence reads ([@B8]).

Cloning of *bla*~NDM~ Genes and Purification of the NDM Proteins
----------------------------------------------------------------

To compare the resistance abilities of *bla*~NDM-20~, *bla*~NDM-5~ and *bla*~NDM-1~, the entire *bla*~NDM-20~, *bla*~NDM-5~, and *bla*~NDM-1~ ORFs were cloned into pHSG398, resulting in recombinant plasmids pHSG398/NDM-20, pHSG398/NDM-5, and pHSG398/NDM-1, respectively ([@B10]). The plasmids were then transformed into *E. coli* DH5α. To assay the effect on enzymatic activity caused by Arg270His, *bla*~NDM-20~ and *bla*~NDM-5~ minus their signal peptide regions were also cloned into the pET28a expression vector, and the resulting plasmids were transformed into *E. coli* BL21 (DE3) (TransGen Biotech, Beijing, China) ([@B10]). The corresponding primers were described in **Supplementary Table [S1](#SM5){ref-type="supplementary-material"}**. All the transformants were confirmed by PCR and sequencing analysis, and their sensitivity to β-lactams were determined as described above. Purification and identification of the NDM proteins was carried out as per the manufacturer's instructions in the following order: (1) purification of recombinant NDM proteins using Ni-nitrilotriacetic acid agarose; (2) cleavage of His-tags using Turbo TEV protease (Accelagen, San Diego, CA, United States); (3) collection of untagged proteins by an additional passage over Ni-nitrilotriacetic acid agarose; (4) SDS-PAGE analysis to assess the purity of the protein products; (5) measurement of protein concentrations by using a Pierce bicinchoninic acid protein assay kit (Thermo Scientific, Waltham, MA, United States); and (6) monitoring β-lactamase activity using nitrocefin (Oxoid, Ltd., Basingstoke, United Kingdom) ([@B10]).

Enzyme Kinetics Assay
---------------------

To assay the catalytic properties of NDM-20 and NDM-5, a kinetic study was conducted. A SpectraMax M5 multi-detection microplate reader (Molecular Devices, Sunnyvale, CA, United States) was used to measure initial hydrolysis rates in 30 mM phosphate buffer (30 μM Zn^2+^, pH 7.0) at 25°C. The hydrolysis rates were then used to determine the *K~m~* and *k*~cat~ values, as well as the *k*~cat~/*K~m~* ratio, using a Lineweaver--Burk plot. All data used to determine the hydrolysis rates were collected from three individual experiments, and wavelengths and extinction coefficients were applied as previously described ([@B3]; [@B15]).

Accession Numbers
-----------------

The sequence of *bla*~NDM-20~ gene has been deposited in GenBank under accession no. KY654092 (sequence of *bla*~NDM-20~ in **Supplementary data [1](#SM3){ref-type="supplementary-material"}**). The complete nucleotide sequence of plasmid pNDM-20 (sequence of pNDM-20 plasmid in **Supplementary data [2](#SM4){ref-type="supplementary-material"}**) has been deposited as GenBank accession no. MF458176.

Results and Discussion
======================

Strain Features
---------------

*Escherichia coli* strain CCD1 was isolated from a swine fecal swab collected from a commercial pig farm in Shandong province, China. The susceptibility testing results showed that *E. coli* CCD1 exhibited high level resistance to all β-lactams examined (**Table [1](#T1){ref-type="table"}**), including aztreonam, carbapenems and combinations of penicillins and β-lactamase inhibitors, but susceptible to gentamicin and colistin. The modified Hodge test was positive for carbapenemase, and subsequent positive result from the MBL combined-disk test further suggested MBL production in *E. coli* CCD1.

The *de novo* assembled genome of CCD1 showed that the number of contigs was 87 and length of N50 was 110,756 bp. PCR and sequencing analysis identified the presence of a novel NDM-encoding gene, designated *bla*~NDM-20~ (GenBank accession no. KY654092). Relative to *bla*~NDM-1~, *bla*~NDM-20~ contained three point mutations at positions 262 (G→T), 460 (A→C), and 809 (G→A), generating amino acid substitutions Val88Leu, Met154Leu, and Arg270His, respectively (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). Homology and phylogenetic analysis of the amino acid sequences of all NDM variants showed that NDM-20 shared the closest evolutionary relationship with NDM-5 (**Figure [1](#F1){ref-type="fig"}**). Notably, only one difference (Arg270His) was observed between the two variants, with this being the first description of a substitution at residue 270. In addition, sequence analysis confirmed the presence of *ampC*, *bla*~CMY~ (aztreonam resistance), and *sul2* (sulfonamide resistance) in strain CCD1 ([@B16]). However, no other ESBL-encoding genes were detected.

![Phylogenetic relationships between New Delhi metallo-β-lactamase (NDM) variants based on amino acid sequences. The tree was generated in MEGA7 and iTOL using the maximum likelihood method. Increased/similar carbapenemase activity of NDM variants was determined from previously reported data and compared with NDM-1. The numbers on the branches signify represent branch lengths.](fmicb-09-00248-g001){#F1}

MLST analysis classified *E. coli* CCD1 as ST1114, suggesting that *E. coli* ST1114 strains have the potential to become a reservoir for the *bla*~NDM-20-like~ gene. A previous study showed that ST1114 *E. coli* isolates are the second largest reservoir of *mcr-1* ([@B12]), while our previous study identified two *E. coli* ST1114 isolates from chickens that were positive for both *mcr-1* and *bla*~NDM-5~ ([@B19]).

Transferability of *bla*~NDM-20~ and Plasmid Analysis
-----------------------------------------------------

Conjugation assays confirmed that *bla*~NDM-20~ could be transferred between *E. coli* strains, although the transfer frequency was only 5.01 × 10^-9^ per donor. Location analysis showed that the *bla*~NDM-20~ probe hybridized to a ∼47 kb plasmid band in the transconjugant DNA extracts (**Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}**), indicating that *bla*~NDM-20~ was located on a transferable plasmid. Subsequently, the entire 46,161-bp *bla*~NDM-20~-harboring plasmid, named pNDM-20 (GenBank accession no. MF458176), was sequenced using a WGS approach (**Figure [2](#F2){ref-type="fig"}**). pNDM-20 was identified as an IncX3-type plasmid, a major type of plasmid mediating transmission of *bla*~NDM~ amongst CRE in China ([@B21]). In pNDM-20, *bla*~NDM-20~ was flanked in the upstream region by IS*3000*-ΔISA*ba125*-IS*5* and downstream by *ble*-*trpF*-*dsbC*-IS*26*-Δ*umuD*, a common *bla*~NDM~ genetic structure that will be responsible for horizontal transfer of *bla*~NDM-20~ among Enterobacteriaceae ([@B17]; [@B10]). No resistance genes other than *bla*~NDM-20~ and *ble*~MBL~ were identified on pNDM-20, supporting the observation that the transconjugants only exhibited resistance to β-lactams, and remained sensitive to aztreonam and other classes of antibiotics.

![The five small external rings represent different *bla*~NDM~-harboring plasmids, shown in different colors that had \>99% identity. The external ring represents the annotation of plasmid pNDM-20 (GenBank accession no. MF458176). Genes are color-coded depending on functional annotations. The internal three rings represent a comparative analysis of pNDM-20 (green) with two *bla*~NDM~-harboring plasmids, 653 (purple) and 655 (yellow) (constructed by BRIG).](fmicb-09-00248-g002){#F2}

Homology analysis revealed 99% nucleotide sequence identity between pNDM-20 and IncX3-type plasmid pNDM-MGR194 (GenBank accession no. KF220657). pNDM-MGR194 was the first reported *bla*~NDM-5~-harboring plasmid, and suggested to be responsible for the evolution and distribution of *bla*~NDM-5~ amongst bacteria ([@B7]). To date, multiple pNDM-MGR194-like plasmids have been identified in bacteria isolated from both humans and animals in China. These plasmids which are 46,161--46,165-bp in length showed \>99% nucleotide sequence identity to pNDM-MGR194, including pAD-19R (GenBank accession no. KX833071), pEC50-NDM7 (GenBank accession no. KX470735), pNDM-QD28 (GenBank accession no. KU167608), and pNDM5_IncX3 (GenBank accession no. KU761328) (**Figure [2](#F2){ref-type="fig"}**). Therefore, the identification of pNDM-20 provides further evidence that IncX3-type *bla*~NDM~-harboring plasmids have become established in bacterial strains originating from both humans and animals, and may circulate via the food chain ([@B7]; [@B10]).

Of note, pNDM-20 had the same backbone structure as the two *bla*~NDM-5~-harboring plasmids (653 and 655) from the ST1114 *E. coli* strains mentioned above. Further analysis showed that the two *bla*~NDM-5~-harboring plasmids could be typed as IncX3 using PlasmidFinder software^[1](#fn01){ref-type="fn"}^ (**Figure [2](#F2){ref-type="fig"}**). Given these plasmids have the same genetic background and plasmid group/type and were all isolated from ST1114 *E. coli* strains, it is possible that *bla*~NDM-20~ evolved from *bla*~NDM-5~ through a series of mutations.

Functional Analysis of *bla*~NDM-20~
------------------------------------

To determine the specific function of *bla*~NDM-20~, *bla*~NDM-20~, the reference gene *bla*~NDM-5~ (containing only a single nucleotide difference at position 809) and *bla*~NDM-1~ were cloned, and the corresponding transformants were examined to determine their antibiotic sensitivity profiles. As shown in **Table [1](#T1){ref-type="table"}**, compared to DH5α+pHSG398, expression of *bla*~NDM-20~, *bla*~NDM-5~, and *bla*~NDM-1~ in *E. coli* DH5α reduced susceptibility to almost all tested β-lactams, including penicillins, cephalosporins, carbapenems, and combinations of penicillins and β-lactamase inhibitors, except aztreonam. In addition, the MICs of piperacillin was not affected by the addition of β-lactamase inhibitors tazobactam. In general, the *bla*~NDM-20~ transformant DH5α+pHSG398/NDM-20 exhibited similar β-lactam resistance to *bla*~NDM-5~ transformant DH5α+pHSG398/NDM-5, although several slight differences were observed. Compared with DH5α+pHSG398/NDM-1, the DH5α+pHSG398/NDM-20 exhibited a fourfold elevation in MIC of ertapenem, indicating that *bla*~NDM-20~ should enhance resistance to ertapenem. All our findings demonstrated that *bla*~NDM-20~ was not as effective as *bla*~NDM-5~, but conferred higher resistance to carbapenems than *bla*~NDM-1~.

Enzyme Activity Analysis
------------------------

To further characterize NDM-20 and explore the influence of the amino acid substitutions on enzymatic activity, NDM-20 and NDM-5 were successfully purified (\>90%) and their kinetic parameters were examined. NDM-20 was able to hydrolyse all β-lactams tested, except aztreonam (**Table [2](#T2){ref-type="table"}**). The *k*~cat~*/K~m~* ratios for ampicillin, cefotaxime, and cefoxitin for NDM-20 were higher than those for NDM-5, but carbapenems *k*~cat~*/K~m~* ratios for NDM-20 were lower than that of NDM-5. These findings resulted from the lower *K~m~* values for some penicillins and cephalosporins and higher values for carbapenems for NDM-20 compared with NDM-5. These results demonstrated that NDM-20 had higher enzymatic activity against some penicillins and cephalosporins and lower activity against carbapenems relative to NDM-5, caused by its enhanced affinity for some penicillins and cephalosporins and depressed affinity for carbapenems.

###### 

Kinetic parameters of NDM-20 and NDM-5*^a^*.

  β-Lactam       NDM-20*^b^*   NDM-5*^b^*   *k*~cat~/*K*~m~ (μM^-1^ s^-1^) ratio for NDM-20/NDM-5                                   
  -------------- ------------- ------------ ------------------------------------------------------- ----------- ------------ ------ ------
  Ampicillin     167 ± 1.9     92 ± 11      0.55                                                    425 ± 27    103 ± 10     0.24   2.29
  Amoxicillin    391 ± 35      15 ± 0.87    0.04                                                    561 ± 17    25 ± 2.6     0.04   1.00
  Penicillin G   313 ± 17      113 ± 2.1    0.36                                                    283 ± 41    99 ± 5.5     0.35   1.03
  Aztreonam      NH^c^         NH           NH                                                      NH          NH           NH     NH
  Cefotaxime     15 ± 0.18     18 ± 0.05    1.2                                                     20 ± 0.89   19 ± 1.4     0.95   1.26
  Cefoxitin      39 ± 0.34     11 ± 0.01    0.28                                                    66 ± 3.3    11 ± 0.45    0.17   1.65
  Ceftazdime     107 ± 8.1     19 ± 1.4     0.18                                                    109 ± 12    19 ± 0.53    0.17   1.06
  Ertapenem      278 ± 9.1     127 ± 5.5    0.46                                                    124 ± 3.8   88 ± 3.2     0.71   0.65
  Imipenem       377 ± 25      147 ± 3.3    0.39                                                    302 ± 14    128 ± 1.2    0.42   0.93
  Meropenem      362 ± 12      160 ± 4.9    0.44                                                    257 ± 12    128 ± 0.65   0.50   0.88

a

The proteins were initially modified with a His-tag, which was removed after purification

.

b

K

m

and k

cat

values are means ± standard deviations from three independent experiments

.

c

NH, no hydrolysis was detected under conditions with substrate concentrations up to 1 mM and enzyme concentrations up to 700 nM

.

NDM-20 contains an Arg270His substitution relative to NDM-5. This substitution may be responsible for the decreased carbapenemase activity of NDM-20 relative to NDM-5. Two other amino acid substitutions (Val88Leu and Met154Leu) were identified in NDM-20 compared with NDM-1. The Val88Leu substitution was reported to decrease the hydrolytic activity of NDM, while the Met154Leu substitution appeared to increase the carbapenemase activity ([@B13]). The active site of NDM-1 is formed by two loops, loop3 and loop10, and crucial amino acid residues binding to two zinc ions, including His120, His122, His189, His250, Cys208, and Asp124 ([@B6]), and the residue 270 was located out of the enzyme active center (**Figure [3](#F3){ref-type="fig"}**). Based on this information, the substitution at residue 270 would not affect the conformation of enzyme active site. It is also possible that the Arg270His substitution may change the protein conformation of NDM-20, thereby altering its hydrolytic activity ([@B23]). However, further experiments are required to confirm which, if any, of these mechanisms contribute to the altered activity of NDM-20 compared with NDM-5.

![Homology model of NDM-20. Protein backbone of NDM-20, shown as a cartoon with the helices and strands. The three amino acid substitutions (L88, L154, and H270) are labeled and colored red.](fmicb-09-00248-g003){#F3}

Conclusion
==========

Our study reports a novel NDM variant, NDM-20, in a ST1114 *E. coli* isolate recovered from food animal in China. Compared to NDM-5, NDM-20 enhances the hydrolytic activity toward some penicillins and cephalosporins, but depresses the carbapenemase activity, which may affect drug strategies for CRE infection. Both the identification of NDM-20 from swine and NDM-17 from chicken suggest that the food animals have become the reservoir of bacteria producing NDM, which may drive NDM evolution to enhanced enzyme activity toward some or all β-lactams. Furthermore, *bla*~NDM-20~ positive bacteria possess the potential capability of dissemination in not only animals but human, becoming a worldwide spread risk. It is time to monitor bacteria producing NDM-20 and other NDM variants in food animals, and coordinate globally to prevent or slow down the NDM evolution.

Author Contributions
====================

JS was responsible for the study design. ZL, JL, XW, and DL assisted in data collection. ZL and YK completed the data interpretation. ZL, YW, and JS wrote the report. All authors revised, reviewed, and approved the final report.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** The study was supported by grants from the National Natural Science Foundation of China (31530076, 31422055, and 81661138002) and the National Basic Research Program of China (2013CB127200).

<https://cge.cbs.dtu.dk/services/>

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fmicb.2018.00248/full#supplementary-material>

###### 

Secondary structure and disorder prediction of NDM-20. Alignment was constructed in Phyre2 using NDM-1 as template (fold library id: c3rkjA in Phyre). The V88L, M154L, and R270H substitutions are boxed in blue.
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###### 

Localization of bla~NDM-20~ on *Escherichia coli* plasmid pNDM-20 by Southern blot hybridization using a bla~NDM-20~ probe **(A)** and by S1-PFGE **(B)**. Lanes 1 and 3, bla~NDM-20~ transconjugant *E. coli* 20J3; lanes 2 and 4, *E. coli* J53; lane M, marker, *Salmonella* H9812.
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The sequence of bla NDM-20 gene has been deposited in GenBank under accession no. KY654092. The sequence of bla NDM-20 gene as follows:
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The complete nucleotide sequence of plasmid pNDM-20 has been deposited as GenBank accession no. MF458176. The sequence of plasmid pNDM-20 as follows:
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Amplified and cloning primers.
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